844-436-7691
Written by Marc Brannigan, Co-Founder & CEO of HempMy Pet. Last updated 15 October 2026.
The short answer: BPC-157 is a 15-amino-acid peptide with dozens of rodent healing studies, exactly one published pharmacokinetic study in dogs, one 28-day beagle safety study, and no controlled trial in dogs showing it works. Integrative vets use it off-label for cruciate injuries, post-surgical recovery, arthritis and gut inflammation. It is not FDA-approved for animals; the only lawful route is a vet-ordered compounded preparation. Avoid it in any dog with a known or suspected tumour.
BPC-157 is the peptide every dog owner asks about first, and the pages that rank for it are mostly written by the people selling it. We make hemp, not peptides, and have no stake in whether you use one. This is the canine evidence as it actually stands in October 2026, who is and is not a candidate, and the route that keeps a vet accountable for the dose.
What BPC-157 Is
Body Protection Compound 157 is a synthetic 15-amino-acid chain based on a protein found in human gastric juice. In rodents it accelerates healing across tendon, ligament, muscle, nerve and gut lining, largely by promoting new blood-vessel growth and upregulating growth-factor signalling. That rodent work — summarised in a 2025 BPC-157 literature review — is the whole scientific case. It is a real mechanism. It is not a dog trial.
The Dog Data, Precisely
| What exists in dogs | What it found | What it does not tell you |
|---|---|---|
| 2022 pharmacokinetic study in beagles (Frontiers in Pharmacology) | Single IV dose 6 µg/kg; IM doses of 6, 30 and 150 µg/kg; seven days of IM at 30 µg/kg. Intramuscular bioavailability ~45–51%. Half-life after IV about 5 minutes. Well tolerated, linear kinetics. | Whether it heals anything. Only absorption and clearance were measured. |
| 28-day beagle safety study (reported in the 2025 BPC-157 literature review) | 0.1, 0.5 and 2 mg/kg a day by injection produced no apparent changes versus saline. | Efficacy, long-term use, use in sick or old dogs, interactions. |
| Integrative-vet case experience | Reports of improvement in cruciate recovery, post-TPLO healing, arthritis mobility and refractory IBD over roughly a decade of off-label use. | Anything controlled. Uncontrolled, unblinded, owner-reported, in a population whose stiff old dogs have good and bad weeks on their own. |
| Controlled efficacy trial in dogs | None published. | — |
For context: the one joint injectable with controlled canine trials and regulatory approval is pentosan polysulfate (Cartrophen Vet), approved in Australia, the UK and Canada — not the US. Oral hemp has five published canine arthritis trials, four positive and one null; we lay them out in Peptides vs CBD for Dogs.
What Vets Use It For, and Who Is a Candidate
Cruciate (CCL) injury, pre- or post-surgery — the most common reason sport-dog owners reach for it. Post-surgical recovery after TPLO, spinal or soft-tissue procedures. Arthritis in a senior whose joint supplements and NSAIDs have stopped doing enough. Gut — IBD, chronic diarrhoea, gastric ulceration — the one case where oral dosing makes sense, because the lining is the target.
A dog with a known or suspected mass. A dog without a diagnosis — a limp is a symptom with nine causes. A dog whose owner expects structural repair: it will not rebuild cartilage, reverse bone-on-bone arthritis or replace surgery on a fully ruptured cruciate. And any dog without a vet willing to prescribe and monitor.
Is your dog a candidate for BPC-157?
Cruciate tear, post-surgical recovery, a gut that will not settle, or a senior whose joint supplements have stopped helping — tell us what is going on and a vet on our team will review whether a protocol, hemp, or both fits your dog.
Got it — thank you.
We'll review your dog's details and reply by email within 48 hours. If a vet needs more — bloodwork dates, imaging, a current medication list — the email will say exactly what.
How It Is Given, and How Long It Takes
Subcutaneous injection under the scruff or flank with an insulin syringe is the route for anything musculoskeletal; oral is the sensible route for gut conditions. Doses are weight-based, in micrograms, set by the prescriber — we deliberately do not publish a chart, because a dosing table on a hemp company's website is not a prescription, and small dogs get doses too small to draw accurately without the vet diluting the vial.
Owners and vets commonly report early changes at one to two weeks (more willing on stairs, less morning stiffness) and meaningful change at four to six. Acute injuries and post-surgical cases move faster than chronic arthritis. If nothing has changed by six weeks, more time rarely helps and the working diagnosis should be revisited. Protocols run four to eight weeks, then stop and reassess.
Safety
The caution that matters most: cancer. BPC-157 and TB-500 work partly by growing new blood vessels, and a tumour needs new blood vessels to grow. No study has shown either peptide causes or accelerates cancer in a dog — and most vets who use them still refuse to give them to any dog with a known or suspected mass. The AVMA puts the lifetime risk at about 1 in 4 dogs, rising to 1 in 2 for dogs 10 and older, which is exactly the senior population these are marketed to. A new lump, unexplained weight loss or a sudden decline is a stop-and-get-it-checked, not a reason to start a peptide.
Interactions: no data alongside carprofen, gabapentin, Librela, prednisone or anything else. Organ disease: organ-protective in healthy rodent organs; unknown in compromised ones. Purity: research vendors carry no requirement that the vial matches the label — impurities were FDA's stated reason for restricting BPC-157 in 2023, and the agency sent warning letters to companies marketing unapproved peptides in August 2026. The chief veterinary officer of the North American Veterinary Community told Forbes this week that dosing is her single biggest concern.
Legality, briefly. There is no FDA-approved BPC-157, TB-500 or KPV product for animals. The lawful route is a licensed veterinarian ordering a compounded preparation under FDA's Guidance for Industry #256, which covers non-food animals, on a vet's order, when no approved option works. FDA's advisory committee voted 8–6 in July 2026 to recommend BPC-157, KPV, TB-500 and MOTS-c for human compounding; the vote is not binding and FDA has not acted. A research-only vial bought online and injected without a vet sits outside all of it. The full timeline is in Peptides for Dogs.
What It Costs
A month of BPC-157 for a 20–30 kg dog runs roughly $50–150 for the peptide alone from a research vendor — with no vet, no verified concentration and no one accountable. A vet-supervised 8-week course is typically quoted at $300–800 including consultations. For a stiff senior whose problem is comfort rather than an injury, a $99 bottle of our 1,000mg hemp oil lasts about two months and has canine trial data behind it.
The daily comfort layer — legal, oral, with canine trial data
250mg Hemp Seed Oil Small dogs · by the drop $49 
1,000mg Hemp Seed Oil Medium and large dogs $99 
Large Dog Hemp Treats 5mg each · easiest daily option $32 Grown on our own certified-organic Colorado farm, formulated in-house, third-party tested every batch. Serving by weight →
If your dog takes any prescription medication, talk to your vet before adding hemp, because it can change how quickly the body clears other drugs. We cover that, and the published safety findings, in hemp and CBD side effects in dogs.
Where Hemp Fits
Different job. Hemp is the daily comfort-and-maintenance layer — oral, legal, $49–99 a bottle, with five published canine arthritis trials, four positive, and a known safety profile (liver-enzyme rises in three of five trials, no serious adverse events). BPC-157 is a time-limited repair protocol with no canine trial yet. Many dogs that are candidates for one are already on the other, and there is no known interaction. If the problem is day-to-day stiffness, start with hemp and a vet check for arthritis stage. If it is a cruciate tear or a gut that will not settle, that is a legitimate question to put to a vet — which is what the form above is for.
Frequently Asked Questions
Where can I get BPC-157 for my dog?
Through a licensed veterinarian who orders a compounded preparation from a pharmacy. That is the only route inside FDA's animal-compounding guidance (GFI #256), and the only one where the concentration is verified and someone is accountable for the dose. Research-only vendors online sell the same compound without a prescription; those vials are not made for animals, are not checked for purity, and sit outside the law. Our free candidate check puts your dog's details in front of a vet.
What peptides can I give my dog?
None is approved for dogs, so it is a veterinary decision, not a menu. The four integrative vets actually use are BPC-157 (joints, soft tissue, gut), TB-500 (tendon and ligament, usually with BPC-157), KPV (gut and skin inflammation) and GHK-Cu (wounds and coat). Oral collagen peptides are a different, food-grade product with a controlled canine arthritis trial behind them.
How long does it take for BPC-157 to kick in?
Owners and vets commonly report early mobility changes at one to two weeks and meaningful change at four to six. Post-surgical and acute-injury cases respond faster than chronic arthritis. If there is no change by six weeks, continuing is unlikely to help and the diagnosis should be revisited.
Is BPC-157 safe for dogs?
Unknown in the way a trial would establish it. A 28-day beagle study found no apparent changes at up to 2 mg/kg a day, a pharmacokinetic study found it well tolerated, and a decade of case series report no serious adverse events. But there are no controlled canine safety trials, no interaction data, and a real theoretical cancer caution because it promotes blood-vessel growth.
What is the silent killer of dogs?
The phrase usually refers to cancer, bloat (GDV), heart disease or kidney disease — conditions that progress without obvious signs until late. It is relevant here because about 1 in 2 dogs over 10 develops cancer, and an angiogenic peptide should never go into a dog with an undiagnosed mass. A senior with a new limp or decline needs a workup before a peptide, not instead of one.
Can BPC-157 heal a torn ACL in a dog?
It will not reattach a fully ruptured cruciate; that is a mechanical problem and surgery has far stronger outcome data. Integrative vets use BPC-157 around surgery — for partial tears managed conservatively and for post-TPLO recovery — on rodent tendon-healing evidence and case experience. We cover this in detail in BPC-157 for Dogs with a Torn CCL.
Can I use human BPC-157 on my dog?
No. Human-oriented vials are reconstituted with bacteriostatic water containing benzyl alcohol, at concentrations that make a small dog's dose too tiny to measure. A veterinary compounding pharmacy prepares a species-appropriate concentration with the right diluent.
Does BPC-157 need to be refrigerated?
Reconstituted peptide is kept refrigerated and used within a few weeks; unreconstituted powder is stored cool and dry. A compounded preparation comes with the pharmacy's own storage instructions — follow those, not a forum.
Want a vet to look at this before you buy a vial?
Two minutes, no purchase. A vet reviews your dog's situation and tells you whether BPC-157 makes sense — including when the answer is a workup first.
Got it — thank you.
We'll review your dog's details and reply by email within 48 hours. If a vet needs more — bloodwork dates, imaging, a current medication list — the email will say exactly what.
Marc co-founded HempMy Pet in 2016 with his business partner Natalie Mondine, the company's COO. They were making the hemp oil for people first and bottled it for pets — one of the first CBD products made for pets. HempMy Pet breeds its own hemp genetics, grows them on its certified-organic Colorado farm, and formulates every batch in-house under human-grade standards — seed to sale, nothing sourced overseas. Every batch is third-party tested and the certificates of analysis are published. More about us.
HempMy Pet ran its own 90-day study of 37 dogs with chronic joint discomfort. Of the 32 that completed it, 30 (93%) showed a benefit, and 94% of owners reported their dog's quality of life had improved. It was overseen by Dr. Robin Downing, DVM, MS of the Downing Center for Animal Pain Management, with Lori Kogan, Ph.D. and Peter W. Hellyer, DVM of Colorado State University's College of Veterinary Medicine & Biomedical Sciences, and published in the Journal of the American Holistic Veterinary Medical Association. Read the methodology.
Why Dr. Downing: in 2005 she became only the third veterinarian in the world credentialed as a Diplomate of the American Academy of Pain Management. She founded the International Veterinary Academy of Pain Management, is a Diplomate of the ACVSMR, a Certified Veterinary Pain Practitioner and a Certified Canine Rehabilitation Practitioner, and was the AVMA's 2020 Bustad Companion Animal Veterinarian of the Year. Chronic joint pain is her life's work. Read the published paper (PDF).
This article is general information for dog owners, not veterinary advice. It is reviewed and updated as new peer-reviewed evidence is published, and where the evidence is thin or negative we say so.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This article is general information, not veterinary advice. If your dog is unwell, contact your veterinarian.
